Stay updated on Inotuzumab Ozogamicin for B-ALL MRD+ Clinical Trial
Sign up to get notified when there's something new on the Inotuzumab Ozogamicin for B-ALL MRD+ Clinical Trial page.

Latest updates to the Inotuzumab Ozogamicin for B-ALL MRD+ Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe site footer revision changed from v3.7.2 to v3.8.0, while the study record content appears unchanged.SummaryDifference0.1%

- Check25 days agoChange DetectedA sitewide NIH notice announces transition updates and says federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference0.6%

- Check32 days agoChange DetectedThe footer’s ClinicalTrials.gov revision label changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check39 days agoChange DetectedThe website footer now displays revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check60 days agoChange DetectedA new revision entry, v3.7.0, is added to the record history and the prior revision, v3.6.6, is removed, signaling an update to the study record’s documentation. This reflects an updated version of the study record rather than changes to participant data or study results.SummaryDifference0.1%

- Check81 days agoChange DetectedThe record history was updated to add a new revision entry v3.6.6 and remove the previous revision v3.6.5, reflecting a change to the page's version history.SummaryDifference0.1%

Stay in the know with updates to Inotuzumab Ozogamicin for B-ALL MRD+ Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inotuzumab Ozogamicin for B-ALL MRD+ Clinical Trial page.